Alzheimer's Disease Research

Alzheimer's disease (AD), the most common type of dementia, is an irreversible and progressive neurodegenerative disorder causing cognitive and functional impairment. It is characterized by formation of protein aggregates and progressive loss of neurons in the central nervous system (CNS). The symptoms of AD include short-term memory loss, confusion, irritability, aggression and mood swings, progressing to long-term memory deficit, withdrawal from social interactions and subsequently a loss in higher central functioning.

Alzheimer's Disease Research Products Targets

Products for Alzheimer's Disease Research - Page 25

  1. Cat.No. Product Name Information/Activity
  2. BCC7394 TC 1698 dihydrochloride 787587-06-8 TC 1698 dihydrochloride chemical structure
  3. BCC7264 α-Bungarotoxin 11032-79-4 α-Bungarotoxin chemical structure
  4. BCC1047 COG 133 ApoE peptide fragment; <span class='symbol'>&#945;</span>7 nAChR antagonist COG 133 chemical structure
  5. BCC5974 α-Conotoxin ImI 156467-85-5 α-Conotoxin ImI chemical structure
  6. BCC6897 Methyllycaconitine citrate 112825-05-5 Methyllycaconitine citrate chemical structure
  7. BCC7028 MG 624 77257-42-2 MG 624 chemical structure
  8. BCC4027 Tropisetron Hydrochloride Tropisetron Hydrochloride (SDZ-ICS-930) is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist with an IC50 of 70.1 ± 0.9 nM for 5-HT3 receptor. Tropisetron Hydrochloride chemical structure
  9. BCC1324 A-867744 A-867744 is a highly potent and selective type II positive allosteric modulator (PAM) of the alpha7 nicotinic acetylcholine receptors (nAChR) with an EC50 of 1.0 μM. A-867744 chemical structure
  10. BCC7788 CCMI CCMI is a potent and selective α7 nAChR-positive allosteric modulator, does not bind to or activate α7 nAChRs via the orthosteric site, and causes significant positive modulation of agonist-induced currents at α7 nAChRs. CCMI has potential in CNS diseases with cognitive dysfunction. CCMI chemical structure
  11. BCC1251 Ivermectin Ivermectin (MK-933) is a broad-spectrum anti-parasite medication used in humans most commonly to treat nematode infections such as onchocerciasis, as well as scabies and lice. Ivermectin (MK-933) is a specific inhibitor of Impα/β1-mediated nuclear import and has potent antiviral activity towards both HIV-1 and dengue virus. It is a positive allosteric effector of P2X4 and the α7 neuronal nicotinic acetylcholine receptor (nAChRs). Ivermectin also inhibits bovine herpesvirus1 (BoHV-1) replication and inhibits BoHV-1 DNA polymerase nuclear import. Ivermectin chemical structure

Items 241 to 250 of 399 total